Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
Dr. Ivan Sanchez Fernandez discusses the main points from his paper on meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.
14 Maj 20192min
Measles in 2019 with Dr. Anthony Fauci
Dr. Anthony Fauci discusses the main points on his paper on measles in 2019. "Measles in 2019--Going Backward" can be found in the New England Journal of Medicine here: https://www.nejm.org/doi/full/1...
13 Maj 20191min
STEP Therapy & Results of AAN Advocacy Efforts for Patients with Neurological Disease
Dr. Jason Crowell discusses STEP therapy and recent advocacy efforts by the AAN at Neurology on the Hill. Read the AAN Capitol Hill Report from April 22nd for more: https://www.aan.com/policy-and-guid...
10 Maj 20192min
Continuum Pearls: Posterior Cortical Atrophy
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses posterior cortical atrophy. To learn more, read the article "Posterior Cortical Atrophy" by Dr. Jonath...
8 Maj 20191min
Treatment of Tics and People with Tourette's Syndrome
Dr. Tamara Pringsheim discusses guideline recommendations on assessment and management of tics in people with Tourette's Syndrome and chronic tic disorders.
7 Maj 20191min
Regulation on Human Gene Editing
New York Times staff writer Pam Belluck discusses the WHO and regulation on human gene editing. Read her March 19, 2019, article here: https://www.nytimes.com/2019/03/19/health/who-panel-demands-a-reg...
6 Maj 20191min
Drug Prices for Lambert Eaton Myasthenic Syndrome
Dr. Jason Crowell discusses skyrocketing costs of a drug used for treatment with Lambert-Eaton myasthenic syndrome.
3 Maj 20191min
Medical Clerkships in Neurology
Dr. Rae Bacharach discusses trends in medical clerkships in neurology.
2 Maj 20191min
